-
1
-
-
0033539092
-
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
-
Finnin, M.S.; Donigian, J.R.; Cohen, A.; Richon, V.M.; Rifkind, R.A.; Marks, P.A.; Breslow, R.; Pavletich, N.P. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 1999, 401, 188-193.
-
(1999)
Nature
, vol.401
, pp. 188-193
-
-
Finnin, M.S.1
Donigian, J.R.2
Cohen, A.3
Richon, V.M.4
Rifkind, R.A.5
Marks, P.A.6
Breslow, R.7
Pavletich, N.P.8
-
2
-
-
27344457467
-
Crystal structure of a bacterial class 2 histone deacetylase homologue
-
Nielsen, T.K.; Hildmann, C.; Dickmanns, A.; Schwienhorst, A.; Ficner, R. Crystal structure of a bacterial class 2 histone deacetylase homologue. J. Mol. Biol. 2005, 354, 107-120.
-
(2005)
J. Mol. Biol
, vol.354
, pp. 107-120
-
-
Nielsen, T.K.1
Hildmann, C.2
Dickmanns, A.3
Schwienhorst, A.4
Ficner, R.5
-
3
-
-
0035961036
-
Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin
-
Sternson, S.M.; Wong, J.C.; Grozinger, C.M.; Schreiber, S.L. Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin. Org. Lett. 2001, 3, 4239-4242.
-
(2001)
Org. Lett
, vol.3
, pp. 4239-4242
-
-
Sternson, S.M.1
Wong, J.C.2
Grozinger, C.M.3
Schreiber, S.L.4
-
4
-
-
0035839136
-
Translating the histone code
-
Jenuwein, T.; Allis, C.D. Translating the histone code. Science 2001, 293, 1074-1080.
-
(2001)
Science
, vol.293
, pp. 1074-1080
-
-
Jenuwein, T.1
Allis, C.D.2
-
5
-
-
0031244521
-
Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs
-
Hassig, C.A.; Schreiber, S.L. Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr. Opin. Chem. Biol. 1997, 1, 300-308.
-
(1997)
Curr. Opin. Chem. Biol
, vol.1
, pp. 300-308
-
-
Hassig, C.A.1
Schreiber, S.L.2
-
7
-
-
78649494321
-
Docking-enabled pharmacophore model for histone deacetylase 8 inhibitors and its application in anti-cancer drug discovery
-
Thangapandian, S.; John, S.; Sakkiah, S.; Lee, K.W. Docking-enabled pharmacophore model for histone deacetylase 8 inhibitors and its application in anti-cancer drug discovery. J. Mol. Graph. Model. 2010, 29, 382-395.
-
(2010)
J. Mol. Graph. Model
, vol.29
, pp. 382-395
-
-
Thangapandian, S.1
John, S.2
Sakkiah, S.3
Lee, K.W.4
-
8
-
-
0036211013
-
Histone acetylation: A switch between repressive and permissive chromatin. Second in review series on chromatin dynamics
-
Eberharter, A.; Becker, P.B. Histone acetylation: A switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep. 2002, 3, 224-229.
-
(2002)
EMBO Rep
, vol.3
, pp. 224-229
-
-
Eberharter, A.1
Becker, P.B.2
-
9
-
-
28644440158
-
Histone deacetylase inhibitors: Discovery and development as anticancer agents
-
Marks, P.A.; Dokmanovic, M. Histone deacetylase inhibitors: Discovery and development as anticancer agents. Expert Opin. Investig. Drugs 2005, 14, 1497-1511.
-
(2005)
Expert Opin. Investig. Drugs
, vol.14
, pp. 1497-1511
-
-
Marks, P.A.1
Dokmanovic, M.2
-
10
-
-
34248649731
-
The Molecular mechanism of HDAC inhibitors in anticancer effects
-
Bi, G.; Jiang, G. The Molecular mechanism of HDAC inhibitors in anticancer effects. Cell. Mol. Immunol. 2006, 3, 285-290.
-
(2006)
Cell. Mol. Immunol
, vol.3
, pp. 285-290
-
-
Bi, G.1
Jiang, G.2
-
11
-
-
26444439216
-
Prospects: Histone deacetylase inhibitors
-
Dokmanovic, M.; Marks, P.A. Prospects: Histone deacetylase inhibitors. J. Cell. Biochem. 2005, 96, 293-304.
-
(2005)
J. Cell. Biochem
, vol.96
, pp. 293-304
-
-
Dokmanovic, M.1
Marks, P.A.2
-
12
-
-
39049159734
-
Histone deacetylase inhibitors: Possible implications for neurodegenerative disorders
-
Hahnen, E.; Hauke, J.; Tränkle, C.; Eyupoglu, I.Y.; Wirth, B.; Blümcke, I. Histone deacetylase inhibitors: Possible implications for neurodegenerative disorders. Expert Opin. Investig. Drugs 2008, 17, 169-184.
-
(2008)
Expert Opin. Investig. Drugs
, vol.17
, pp. 169-184
-
-
Hahnen, E.1
Hauke, J.2
Tränkle, C.3
Eyupoglu, I.Y.4
Wirth, B.5
Blümcke, I.6
-
13
-
-
34548301409
-
Histone deacetylases: Focus on the nervous system
-
Morrison, B.E.; Majdzadeh, N.; D'Mello, S.R. Histone deacetylases: Focus on the nervous system. Cell. Mol. Life Sci. 2007, 64, 2258-2269.
-
(2007)
Cell. Mol. Life Sci
, vol.64
, pp. 2258-2269
-
-
Morrison, B.E.1
Majdzadeh, N.2
D'mello, S.R.3
-
14
-
-
0141506887
-
Valproic acid increases the SMN2 protein level: A well-known drug as a potential therapy for spinal muscular atrophy
-
Brichta, L.; Hofmann, Y.; Hahnen, E.; Siebzehnrubl, F.A.; Raschke, H.; Blumcke, I.; Eyupoglu, I.Y.; Wirth, B. Valproic acid increases the SMN2 protein level: A well-known drug as a potential therapy for spinal muscular atrophy. Hum. Mol. Genet. 2003, 12, 2481-2489.
-
(2003)
Hum. Mol. Genet
, vol.12
, pp. 2481-2489
-
-
Brichta, L.1
Hofmann, Y.2
Hahnen, E.3
Siebzehnrubl, F.A.4
Raschke, H.5
Blumcke, I.6
Eyupoglu, I.Y.7
Wirth, B.8
-
15
-
-
0037452775
-
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease
-
Hockly, E.; Richon, V.M.; Woodman, B.; Smith, D.L.; Zhou, X.; Rosa, E.; Sathasivam, K.; Ghazi-Noori, S.; Mahal, A.; Lowden, P.A.; et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA 2003, 100, 2041-2046.
-
(2003)
Proc. Natl. Acad. Sci. USA
, vol.100
, pp. 2041-2046
-
-
Hockly, E.1
Richon, V.M.2
Woodman, B.3
Smith, D.L.4
Zhou, X.5
Rosa, E.6
Sathasivam, K.7
Ghazi-Noori, S.8
Mahal, A.9
Lowden, P.A.10
-
16
-
-
34047218122
-
HDAC inhibitors as anti-inflammatory agents
-
Adcock, I.M. HDAC inhibitors as anti-inflammatory agents. Br. J. Pharmacol. 2009, 150, 829-831.
-
(2009)
Br. J. Pharmacol
, vol.150
, pp. 829-831
-
-
Adcock, I.M.1
-
17
-
-
41149141516
-
Histone deacetylases: Target enzymes for cancer therapy
-
Mottet, D.; Castronova, V. Histone deacetylases: Target enzymes for cancer therapy. Clin. Exp. Metastasis 2008, 25, 183-189.
-
(2008)
Clin. Exp. Metastasis
, vol.25
, pp. 183-189
-
-
Mottet, D.1
Castronova, V.2
-
18
-
-
39149114438
-
HDAC.Inhibitors: A potential new category of anti-tumor agents
-
Pan, L.; Lu, J.; Huang, B. HDAC Inhibitors: A potential new category of anti-tumor agents. Cell. Mol. Immunol. 2007, 4, 337-343.
-
(2007)
Cell. Mol. Immunol
, vol.4
, pp. 337-343
-
-
Pan, L.1
Lu, J.2
Huang, B.3
-
19
-
-
34247376560
-
Design and evaluation of linkerless hydroxamic acids as selective HDAC8 inhibitors
-
Krennhrubec, K.; Marshall, B.L.; Hedglin, M.; Verdin, E.; Ulrich, S.M. Design and evaluation of linkerless hydroxamic acids as selective HDAC8 inhibitors. Bioorg. Med. Chem. Lett. 2007, 17, 2874-2878.
-
(2007)
Bioorg. Med. Chem. Lett
, vol.17
, pp. 2874-2878
-
-
Krennhrubec, K.1
Marshall, B.L.2
Hedglin, M.3
Verdin, E.4
Ulrich, S.M.5
-
20
-
-
43949130430
-
Structural origin of selectivity in class II-selective histone deacetylase inhibitors
-
Estiu, G.; Greenberg, E.; Harrison, C.B.; Kwiatkowski, N.P.; Mazitschek, R.; Bradner, J.E.; Wiest, O. Structural origin of selectivity in class II-selective histone deacetylase inhibitors. J. Med. Chem. 2008, 51, 2898-2906.
-
(2008)
J. Med. Chem
, vol.51
, pp. 2898-2906
-
-
Estiu, G.1
Greenberg, E.2
Harrison, C.B.3
Kwiatkowski, N.P.4
Mazitschek, R.5
Bradner, J.E.6
Wiest, O.7
-
21
-
-
4143101371
-
Class 1 histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation
-
Park, J.H.; Jung, Y.; Kim, T.; Kim, S.; Jong, H.S.; Lee, J.W.; Kim, D.K.; Lee, J.S.; Kim, N.K.; Kim, T.Y.; et al. Class 1 histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Clin. Cancer Res. 2004, 10, 5271-5281.
-
(2004)
Clin. Cancer Res
, vol.10
, pp. 5271-5281
-
-
Park, J.H.1
Jung, Y.2
Kim, T.3
Kim, S.4
Jong, H.S.5
Lee, J.W.6
Kim, D.K.7
Lee, J.S.8
Kim, N.K.9
Kim, T.Y.10
-
22
-
-
21244467166
-
Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies
-
Bhalla, K.N. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies. J. Clin. Oncol. 2005, 23, 3971-3993.
-
(2005)
J. Clin. Oncol
, vol.23
, pp. 3971-3993
-
-
Bhalla, K.N.1
-
23
-
-
35548947488
-
Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex
-
Vannini, A.; Volpari, C.; Gallinari, P.; Jones, P.; Mattu, M.; Carfí, A.; de Francesco, R.; Steinkühler, C.; Di Marco, S. Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex. EMBO Rep. 2007, 9, 879-884.
-
(2007)
EMBO Rep
, vol.9
, pp. 879-884
-
-
Vannini, A.1
Volpari, C.2
Gallinari, P.3
Jones, P.4
Mattu, M.5
Carfí, A.6
de Francesco, R.7
Steinkühler, C.8
Di Marco, S.9
-
24
-
-
33947313218
-
HDACs, histone deacetylation and gene transcription: From molecular biology to cancer therapeutics
-
Gallinari, P.; Di Marco, S.; Jones, P.; Pallaoro, M.; Steinkühler, C. HDACs, histone deacetylation and gene transcription: From molecular biology to cancer therapeutics. Cell Res. 2007, 17, 195-211.
-
(2007)
Cell Res
, vol.17
, pp. 195-211
-
-
Gallinari, P.1
Di Marco, S.2
Jones, P.3
Pallaoro, M.4
Steinkühler, C.5
-
25
-
-
43749109171
-
A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas HDAC8-specific inhibitor PCI-34051 in T-cell lymphoma
-
Balasubramanian, S.; Ramos, J.; Luo, W.; Sirisiawad, M.; Verner, E.; Buggy, J.J. A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas HDAC8-specific inhibitor PCI-34051 in T-cell lymphoma. Leukemia 2008, 22, 1026-1034.
-
(2008)
Leukemia
, vol.22
, pp. 1026-1034
-
-
Balasubramanian, S.1
Ramos, J.2
Luo, W.3
Sirisiawad, M.4
Verner, E.5
Buggy, J.J.6
-
26
-
-
34248193440
-
Histone deacetylase inhibitors in cancer therapy
-
Rasheed, W.K.; Johnstone, R.W.; Prince, H.M. Histone deacetylase inhibitors in cancer therapy. Expert Opin. Investig. Drugs 2007, 16, 659-677.
-
(2007)
Expert Opin. Investig. Drugs
, vol.16
, pp. 659-677
-
-
Rasheed, W.K.1
Johnstone, R.W.2
Prince, H.M.3
-
27
-
-
73349116582
-
Docking of hydroxamic acids into HDAC1 and HDAC8: A rationalization of activity trends and selectivities
-
Gabriella, O.; Francesco, D.C.; Adriano, M. Docking of hydroxamic acids into HDAC1 and HDAC8: A rationalization of activity trends and selectivities. J. Chem. Inf. Model. 2009, 49, 2774-2785.
-
(2009)
J. Chem. Inf. Model
, vol.49
, pp. 2774-2785
-
-
Gabriella, O.1
Francesco, D.C.2
Adriano, M.3
-
28
-
-
80052814243
-
Isoform-selective HDAC inhibitors: Closing in on translational medicine for the heart
-
McKinsey, T.A. Isoform-selective HDAC inhibitors: Closing in on translational medicine for the heart. J. Mol. Cell. Cardiol. 2011, 51, 491-496.
-
(2011)
J. Mol. Cell. Cardiol
, vol.51
, pp. 491-496
-
-
McKinsey, T.A.1
-
29
-
-
77953139148
-
On the inhibition of histone deacetylase 8
-
Estiu, G.; West, N.; Mazitschek, R.; Greenberg, E.; Bradner, J.E.; Wiest, O. On the inhibition of histone deacetylase 8. Bioorg. Med. Chem. 2010, 18, 4103-4110.
-
(2010)
Bioorg. Med. Chem
, vol.18
, pp. 4103-4110
-
-
Estiu, G.1
West, N.2
Mazitschek, R.3
Greenberg, E.4
Bradner, J.E.5
Wiest, O.6
-
30
-
-
56049097649
-
Molecular dynamics simulation study of PTP1B with allosteric inhibitor and its application in receptor based pharmacophore modeling
-
Bharatham, K.; Bharatham, N.; Kwon, Y.J.; Lee, K.W. Molecular dynamics simulation study of PTP1B with allosteric inhibitor and its application in receptor based pharmacophore modeling. J. Comput. Aided Mol. Des. 2008, 22, 925-933.
-
(2008)
J. Comput. Aided Mol. Des
, vol.22
, pp. 925-933
-
-
Bharatham, K.1
Bharatham, N.2
Kwon, Y.J.3
Lee, K.W.4
-
31
-
-
14944359976
-
Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors
-
Deng, J.; Lee, K.W.; Sanchez, T.; Cui, M.; Neamati, N.; Brigg, J.M. Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors. J. Med. Chem. 2005, 48, 1496-1505.
-
(2005)
J. Med. Chem
, vol.48
, pp. 1496-1505
-
-
Deng, J.1
Lee, K.W.2
Sanchez, T.3
Cui, M.4
Neamati, N.5
Brigg, J.M.6
-
32
-
-
84155183359
-
-
version 4.1 UserGuide; CCDC Software Ltd.: Cambridge, UK
-
GOLD, version 4.1 UserGuide; CCDC Software Ltd.: Cambridge, UK, 2010.
-
(2010)
GOLD
-
-
-
33
-
-
19444379914
-
Theoretical study revealing the functioning of a novel combination of catalytic motifs in histone deacetylase
-
Vanommeslaeghe, K.; de Proft, F.; Loverix, S.; Tourwe, D.; Geerlings, P. Theoretical study revealing the functioning of a novel combination of catalytic motifs in histone deacetylase. Bioorg. Med. Chem. 2005, 13, 3987-3992.
-
(2005)
Bioorg. Med. Chem
, vol.13
, pp. 3987-3992
-
-
Vanommeslaeghe, K.1
de Proft, F.2
Loverix, S.3
Tourwe, D.4
Geerlings, P.5
-
34
-
-
77955808765
-
A proton-shuttle reaction mechanism for histone deacetylase 8 and the catalytic role of metal ions
-
Wu, R.; Wang, S.; Zhou, N.; Cao, Z.; Zhang, Y. A proton-shuttle reaction mechanism for histone deacetylase 8 and the catalytic role of metal ions. J. Am. Chem. Soc. 2010, 132, 9471-9479.
-
(2010)
J. Am. Chem. Soc
, vol.132
, pp. 9471-9479
-
-
Wu, R.1
Wang, S.2
Zhou, N.3
Cao, Z.4
Zhang, Y.5
-
35
-
-
77956182637
-
Ligand and structure based pharmacophore modeling to facilitate novel histone deacetylase 8 inhibitor design
-
Thangapandian, S.; John, S.; Sakkiah, S.; Lee, K.W. Ligand and structure based pharmacophore modeling to facilitate novel histone deacetylase 8 inhibitor design. Eur. J. Med. Chem. 2010, 45, 4409-4417.
-
(2010)
Eur. J. Med. Chem
, vol.45
, pp. 4409-4417
-
-
Thangapandian, S.1
John, S.2
Sakkiah, S.3
Lee, K.W.4
-
36
-
-
0034663486
-
Cloning and characterization of a novel human histone deacetylase, HDAC8
-
Buggy, J.J.; Sideris, M.L.; Mak, P.; Lorimer, D.D.; McIntosh, B.; Clark, J.M. Cloning and characterization of a novel human histone deacetylase, HDAC8. Biochem. J. 2000, 350, 199-205.
-
(2000)
Biochem. J
, vol.350
, pp. 199-205
-
-
Buggy, J.J.1
Sideris, M.L.2
Mak, P.3
Lorimer, D.D.4
McIntosh, B.5
Clark, J.M.6
-
37
-
-
33646241042
-
An empirical analysis of research topic query processing
-
SciFinder scholar
-
Wagner, A.B. SciFinder scholar 2006: An empirical analysis of research topic query processing. J. Chem. Inf. Model. 2006, 46, 767-774.
-
(2006)
J. Chem. Inf. Model
, vol.2006
, Issue.46
, pp. 767-774
-
-
Wagner, A.B.1
-
38
-
-
75549087817
-
An overview of the PubChem BioAssay resource
-
Wang, Y.; Bolton, E.; Dracheva, S.; Karapetyan, K.; Shoemaker, B.A.; Suzek, T.O.; Wang, J.; Xiao, J.; Zhang, J.; Bryant, S.H. An overview of the PubChem BioAssay resource. Nucleic Acids Res. 2010, 38, D255-D266.
-
(2010)
Nucleic Acids Res
, vol.38
-
-
Wang, Y.1
Bolton, E.2
Dracheva, S.3
Karapetyan, K.4
Shoemaker, B.A.5
Suzek, T.O.6
Wang, J.7
Xiao, J.8
Zhang, J.9
Bryant, S.H.10
-
39
-
-
6344222799
-
Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor
-
Vannini, A.; Volpari, C.; Filocamo, G.; Casavola, E.C.; Brunetti, M.; Renzoni, D.; Chakravarty, P.; Paolini, C.; Francesco, R.D.; Gallinari, P.; et al. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. Proc. Natl. Acad. Sci. USA 2004, 101, 15064-15069.
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 15064-15069
-
-
Vannini, A.1
Volpari, C.2
Filocamo, G.3
Casavola, E.C.4
Brunetti, M.5
Renzoni, D.6
Chakravarty, P.7
Paolini, C.8
Francesco, R.D.9
Gallinari, P.10
-
40
-
-
3142562372
-
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases
-
Somoza, L.R.; Skene, R.J.; Katz, B.A.; Mol, C.; Ho, J.D.; Jennings, A.J.; Luong, C.; Arvai, A.; Buggy, J.J.; Chi, E.; et al. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure 2004, 12, 1325-1334.
-
(2004)
Structure
, vol.12
, pp. 1325-1334
-
-
Somoza, L.R.1
Skene, R.J.2
Katz, B.A.3
Mol, C.4
Ho, J.D.5
Jennings, A.J.6
Luong, C.7
Arvai, A.8
Buggy, J.J.9
Chi, E.10
-
41
-
-
58149144730
-
Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors
-
Dowling, D.P.; Gantt, S.L.; Gattis, S.G.; Fierke, C.A.; Christianson, D.W. Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors. Biochemistry 2008, 47, 13554-13563.
-
(2008)
Biochemistry
, vol.47
, pp. 13554-13563
-
-
Dowling, D.P.1
Gantt, S.L.2
Gattis, S.G.3
Fierke, C.A.4
Christianson, D.W.5
-
42
-
-
77953664293
-
Structures of metal-substituted human histone deacetylase 8 provide mechanistic inferences on biological function
-
Dowling, D.P.; Gattis, S.G.; Fierke, C.A.; Christianson, D.W. Structures of metal-substituted human histone deacetylase 8 provide mechanistic inferences on biological function. Biochemistry 2010, 49, 5048-5056.
-
(2010)
Biochemistry
, vol.49
, pp. 5048-5056
-
-
Dowling, D.P.1
Gattis, S.G.2
Fierke, C.A.3
Christianson, D.W.4
-
43
-
-
84155177165
-
Biaryl Linked Hydroxamates: Preparation and Pharmaceutical Applications
-
Stunkel, W.; Wang, H.; Yin, Z. Biaryl Linked Hydroxamates: Preparation and Pharmaceutical Applications. U.S. Patent 2007/0167499 A1, 19 July 2007.
-
(2007)
U.S. Patent 2007/0167499
, vol.A1
, pp. 19
-
-
Stunkel, W.1
Wang, H.2
Yin, Z.3
-
44
-
-
84155173755
-
Uses of Selective Inhibitors of HDAC8 for Treatment of T-Cell Proliferative Disorders
-
Joseph, J.B.; Sriram, B. Uses of Selective Inhibitors of HDAC8 for Treatment of T-Cell Proliferative Disorders. U.S. Patent 2008/0112889 A1, 15 May 2008.
-
(2008)
U.S. Patent 2008/0112889
, vol.A1
, pp. 15
-
-
Joseph, J.B.1
Sriram, B.2
-
45
-
-
79952275745
-
Structural determination of three different series of compounds as Hsp90 inhibitors using 3D-QSAR modeling, molecular docking and molecular dynamics methods
-
Liu, J.; Wang, F.; Ma, Z.; Wang, X.; Wang, Y. Structural determination of three different series of compounds as Hsp90 inhibitors using 3D-QSAR modeling, molecular docking and molecular dynamics methods. Int. J. Mol. Sci. 2011, 12, 946-970.
-
(2011)
Int. J. Mol. Sci
, vol.12
, pp. 946-970
-
-
Liu, J.1
Wang, F.2
Ma, Z.3
Wang, X.4
Wang, Y.5
-
46
-
-
46249092554
-
GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation
-
Hess, B.; Kutzner, C.; van der Spoel, D.; Lindahl, E. GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory Comput. 2008, 4, 435-447.
-
(2008)
J. Chem. Theory Comput
, vol.4
, pp. 435-447
-
-
Hess, B.1
Kutzner, C.2
van der Spoel, D.3
Lindahl, E.4
-
47
-
-
84155173761
-
-
version 4; University of Groningen: Groningen, The Netherlands, Manual pages
-
GROMACS, version 4; University of Groningen: Groningen, The Netherlands; 2005; Manual pages.
-
(2005)
GROMACS
-
-
-
48
-
-
84855685580
-
-
version 96; Swiss Federal Institute of Technology: Zürich, Switzerland
-
GROMOS, version 96; Swiss Federal Institute of Technology: Zürich, Switzerland; 1996.
-
(1996)
GROMOS
-
-
-
49
-
-
7544226311
-
PRODRG: A tool for high-throughput crystallography of protein-ligand complexes
-
Schuttelkopf, A.W.; van Aalten, D.M. PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 2004, 60, 1355-1363.
-
(2004)
Acta Crystallogr. D Biol. Crystallogr
, vol.60
, pp. 1355-1363
-
-
Schuttelkopf, A.W.1
van Aalten, D.M.2
-
50
-
-
33846086933
-
Canonical sampling through velocity rescaling
-
Bussi, G.; Donadio, D.; Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 2007, 126, 014101:1-014101:7.
-
(2007)
J. Chem. Phys
, vol.126
-
-
Bussi, G.1
Donadio, D.2
Parrinello, M.3
-
51
-
-
33645961739
-
A smooth particle mesh Ewald method
-
Essmann, U.; Perera, L.; Berkowitz, M.L.; Darden, T.; Lee, H.; Pedersen, L.G. A smooth particle mesh Ewald method. J. Chem. Phys. 1995, 103, 8577-8593.
-
(1995)
J. Chem. Phys
, vol.103
, pp. 8577-8593
-
-
Essmann, U.1
Perera, L.2
Berkowitz, M.L.3
Darden, T.4
Lee, H.5
Pedersen, L.G.6
-
52
-
-
37249062877
-
-
version 2.5; Accelrys Inc.: San Diego, CA, USA
-
Discovery Studio, version 2.5; Accelrys Inc.: San Diego, CA, USA, 2009.
-
(2009)
Discovery Studio
-
-
-
53
-
-
33645847864
-
Carbonyl- and sulfur-containing analogs of suberoylanilide hydroxamic acid: Potent inhibition of histone deacetylases
-
Wenxin, G.; Inna, N.; Ronald, D.S.; Curt, M.H.; Richard, B.S. Carbonyl- and sulfur-containing analogs of suberoylanilide hydroxamic acid: Potent inhibition of histone deacetylases. Bioorg. Med. Chem. 2006, 14, 3320-3329.
-
(2006)
Bioorg. Med. Chem
, vol.14
, pp. 3320-3329
-
-
Wenxin, G.1
Inna, N.2
Ronald, D.S.3
Curt, M.H.4
Richard, B.S.5
-
54
-
-
0346099272
-
Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group
-
Tom, Y.H.W.; Christian, H.; Yiqin, W.; Sheng, D.; Peter, G.S. Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group. Bioorg. Med. Chem. Lett. 2004, 14, 449-453.
-
(2004)
Bioorg. Med. Chem. Lett
, vol.14
, pp. 449-453
-
-
Tom, Y.H.W.1
Christian, H.2
Yiqin, W.3
Sheng, D.4
Peter, G.S.5
-
55
-
-
84155177164
-
Methods for Specifically Inhibiting Histone-7 and 8
-
Jeffrey, M.B.; Zuomei, L.; Daniel, D.; Claire, B. Methods for Specifically Inhibiting Histone-7 and 8. U.S. Patent 2004/0072770 A1, 15 April 2004.
-
(2004)
U.S. Patent 2004/0072770
, vol.A1
, pp. 15
-
-
Jeffrey, M.B.1
Zuomei, L.2
Daniel, D.3
Claire, B.4
-
56
-
-
84155177162
-
Benzimidazole Derivatives: Preparation and Pharmaceutical Applications
-
Dizhong, C.; Weiping, D.; Kand, S.; Hong, Y.S.; Eric, T.S.; Niefang, Y.; Yong, Z. Benzimidazole Derivatives: Preparation and Pharmaceutical Applications. U.S. Patent 2007/0043043 A1, 22 February 2007.
-
(2007)
U.S. Patent 2007/0043043
, vol.A1
, pp. 22
-
-
Dizhong, C.1
Weiping, D.2
Kand, S.3
Hong, Y.S.4
Eric, T.S.5
Niefang, Y.6
Yong, Z.7
-
57
-
-
84155177165
-
Biaryl Linked Hydroxamates: Preparation and Pharmaceutical Applications
-
Walter, S.; Haishan, W.; Zheng, Y. Biaryl Linked Hydroxamates: Preparation and Pharmaceutical Applications. U.S. Patent 2007/0167499 A1, 19 July 2007.
-
(2007)
U.S. Patent 2007/0167499
, vol.A1
, pp. 19
-
-
Walter, S.1
Haishan, W.2
Zheng, Y.3
-
58
-
-
84155177163
-
Aclyurea Connected and Sulfonamide Connected Hydroxamates
-
Ze-Yi, L.; Haishan, W.; Yan, Z. Aclyurea Connected and Sulfonamide Connected Hydroxamates. U.S. Patent 2008/0070954 A1, 20 March 2008.
-
(2008)
U.S. Patent 2008/0070954
, vol.A1
, pp. 20
-
-
Ze-Yi, L.1
Haishan, W.2
Yan, Z.3
-
59
-
-
84155173755
-
Uses of Selective Inhibitors of HDAC8 for Treatment of T-Cell Proliferative Disorders
-
Joseph, J.B.; Sriram, B. Uses of Selective Inhibitors of HDAC8 for Treatment of T-Cell Proliferative Disorders. U.S. Patent 2008/0112889 A1, 15 May 2008.
-
(2008)
U.S. Patent 2008/0112889
, vol.A1
, pp. 15
-
-
Joseph, J.B.1
Sriram, B.2
-
60
-
-
13344270285
-
Pharmacophore definition and 3D searches
-
Langer, L.; Wolber, G. Pharmacophore definition and 3D searches. Drug Discov. Today Technol. 2004, 1, 203-207.
-
(2004)
Drug Discov. Today Technol
, vol.1
, pp. 203-207
-
-
Langer, L.1
Wolber, G.2
-
61
-
-
79957807265
-
Novel natural inhibitors of CYP1A2 identified by in silico and in vitro screening
-
Zhu, R.; Hu, L.; Li, H.; Su, J.; Cao, Z.; Zhang, W. Novel natural inhibitors of CYP1A2 identified by in silico and in vitro screening. Int. J. Mol. Sci. 2011, 12, 3250-3262.
-
(2011)
Int. J. Mol. Sci
, vol.12
, pp. 3250-3262
-
-
Zhu, R.1
Hu, L.2
Li, H.3
Su, J.4
Cao, Z.5
Zhang, W.6
-
62
-
-
80052160108
-
Reviewing ligand-based rational drug design: The search for an ATP synthase inhibitor
-
Lee, C.-H.; Huang, H.-C.; Juan, H.-F. Reviewing ligand-based rational drug design: The search for an ATP synthase inhibitor. Int. J. Mol. Sci. 2011, 12, 5304-5318.
-
(2011)
Int. J. Mol. Sci
, vol.12
, pp. 5304-5318
-
-
Lee, C.-H.1
Huang, H.-C.2
Juan, H.-F.3
-
63
-
-
0035289779
-
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
-
Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001, 46, 3-26.
-
(2001)
Adv. Drug Deliv. Rev
, vol.46
, pp. 3-26
-
-
Lipinski, C.A.1
Lombardo, F.2
Dominy, B.W.3
Feeney, P.J.4
-
64
-
-
0041919542
-
Improved protein-ligand docking using GOLD
-
Verdonk, M.L.; Cole, J.C.; Hartshorn, M.J.; Murray, C.W.; Taylor, R.D. Improved protein-ligand docking using GOLD. Proteins 2003, 52, 609-623.
-
(2003)
Proteins
, vol.52
, pp. 609-623
-
-
Verdonk, M.L.1
Cole, J.C.2
Hartshorn, M.J.3
Murray, C.W.4
Taylor, R.D.5
-
65
-
-
77954274507
-
Evaluation of the performance of four molecular docking programs on a diverse set of protein-ligand complexes
-
Li, X.; Li, Y.; Cheng, T.; Liu, Z.; Wang, R. Evaluation of the performance of four molecular docking programs on a diverse set of protein-ligand complexes. J. Comput. Chem. 2010, 31, 2109-2125.
-
(2010)
J. Comput. Chem
, vol.31
, pp. 2109-2125
-
-
Li, X.1
Li, Y.2
Cheng, T.3
Liu, Z.4
Wang, R.5
-
66
-
-
79251524915
-
Can we trust docking results? Evaluation of seven commonly used programs on PDBbind database
-
Plewczynski, D.; Lazniewski, M.; Augustyniak, R.; Ginalski, K. Can we trust docking results? Evaluation of seven commonly used programs on PDBbind database. J. Comput. Chem. 2011, 32, 742-755.
-
(2011)
J. Comput. Chem
, vol.32
, pp. 742-755
-
-
Plewczynski, D.1
Lazniewski, M.2
Augustyniak, R.3
Ginalski, K.4
-
67
-
-
39749179732
-
Molecular docking study of the interactions between the thioesterase domain of human fatty acid synthase and its ligands
-
Cheng, F.; Wang, Q.; Chen, M.; Quiocho, F.A.; Ma, J. Molecular docking study of the interactions between the thioesterase domain of human fatty acid synthase and its ligands. Proteins 2008, 70, 1228-1234.
-
(2008)
Proteins
, vol.70
, pp. 1228-1234
-
-
Cheng, F.1
Wang, Q.2
Chen, M.3
Quiocho, F.A.4
Ma, J.5
-
68
-
-
84155191481
-
-
version 2.2.0; Molegro ApS: Aarhus, Denmark
-
Molegro Molecular Viewer, version 2.2.0; Molegro ApS: Aarhus, Denmark, 2011
-
(2011)
Molegro Molecular Viewer
-
-
|